medRxivGenetic & Genomic MedicinePreprint
Sickle Cell Disease Demographics and Clinical Epidemiology in Gambian Urban and Rural Cohorts Retrospective Analysis
Mustapha DibbaseyiD, Kevin Kum EsohiD, Bubacarr SussoiD, Karen ForrestiD, Bakary J. SonkoiD, Lamin MakaloiD, Eniyou Cheryll OrieroiD, Ndong Ignatius ChengiD, Lucas Naam-Kayagre Amenga-EtegoiD, Carla CeramiiD, Alfred Amambua‐NgwaiD
- Citations
- 0
Abstract
Globally, approximately 75% of sickle cell disease (SCD) cases occurs in sub-Saharan Africa, yet empirical data on its natural history, clinical burden, and modifiers remain scarce in the region. This retrospective study describes the demographic characteristics, complications, and routine care and examines how non-genetic factors and blood markers relate to disease severity. We analysed 8402 medical records from 840 SCD patients with confirmed HbSS genotype registered in MRCG Keneba and Fajara clinics (NKeneba=148; NFajara=692). A generalised linear model was employed to estimates association of non-genetic correlates, blood biomarkers, routine care medications with disease severity. Here we showed 67% of patients in Keneba cohort and 92% of those in Fajara cohort had no documented SCD-related chronic complication. Despite no documented evidence of hydroxyurea use, SCD crises (Keneba=0.57, Fajara=0.63) and infections (Keneba=0.53, Fajara=0.35) rates -expressed per patient-year-were low in both cohorts with 99% patients experiencing [≤]3 SCD crises per patient-year. Age at diagnosis, gender and seasonality were not significantly associated with SCD crises or other clinical outcomes/events rates. Each additional folic acid prescription was associated with higher haemoglobin(g/dL) (total folic acid prescriptions: {beta}Fajara=1.31,P=0.005; {beta}Keneba=1.20,P<0.001). Penicillin prophylaxis was associated with reduced rate of infection (total Pen V prescriptions: IRRFajara=0.85,P=0.002; IRRKeneba=0.93,P=0.002) and SCD crises (IRRFajara=0.67,P=0.001; IRRKeneba=0.87,P=0.001). This study found low acute events rates and chronic complications prevalence in the absence hydroxyurea use. No significant associations were observed between non-genetic correlates and clinical events, but the study highlighted the needs for continues folic acid supplementation and penicillin prophylaxis due to their observed beneficial effects.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Views and Experiences of Parents and Physicians on the Care Provided to Children with Sickle Cell Disease in Cameroon
E. Agborndip, B. Momo Kadia, … H. Bedford·bioRxiv·Feb 29, 2020
- AWARENESS AND ACCEPTABILITY OF PRE-MARITAL SCREENING FOR SICKLE CELL AMONG UNIVERSITY STUDENTS IN KENYA
Sammy Mwatela Rua, Lijah Ogola, Syokau Ilovi·Journal of Kenya Assocation of PhysiciansPeer-reviewed·Jan 1, 2026
- Variation and impact of polygenic hematological traits in monogenic sickle cell disease
Thomas Pincez, Ken Sin Lo, … Guillaume Lettre·HaematologicaPeer-reviewed·Oct 13, 2022
- The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria
Oyesola Oyewole Ojewunmi, Titilope Adenike Adeyemo, … Stephan Menzel·Human Molecular GeneticsPeer-reviewed·Jan 18, 2024
- Exploring Pharmacogenetic Factors Influencing Hydroxyurea Response in Tanzanian Sickle Cell Disease Patients: A Genomic Medicine Approach.
Siana Watoky Nkya, Collin Nzunda, … Julie Makani·The Pharmacogenomics JournalPeer-reviewed·Apr 23, 2025
- A portable molecular laboratory for rapid genotyping in the field: application to sickle cell disease
Fabienne Grunder, Anne-Flore Hämmerli, … Hugues Abriel·medRxiv·May 12, 2026